FibroBiologics (FBLG) Proxy filing summary

Executive summary

• Special Meeting scheduled for September 17, 2026, with voting available online or virtually.

• Shareholders are asked to approve the issuance of up to 8,448,980 shares of common stock upon exercise of outstanding warrants.

Voting matters and shareholder proposals

• Proposal to approve issuance of up to 8,163,266 shares under warrants from a Securities Purchase Agreement dated June 25, 2026.

• Proposal to approve issuance of up to 285,714 shares under warrants from an Engagement Letter with H.C. Wainwright & Co., LLC.

• Board recommends voting in favor of all proposals.

• Additional business may be addressed if properly brought before the meeting.

Shareholder rights and capital structure

• Shareholders have the right to vote virtually or online by September 16, 2026.

• Proposals impact the potential dilution and capital structure through new share issuances.